Alzheimer’s disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. In most people with Alzheimer’s disease, symptoms first appear after age 65. Estimates vary, but experts suggest that as many as 5.1 million Americans may have Alzheimer’s disease. Currently there is no cure for Alzheimer’s disease.
Feinstein Institute researchers are studying genes that put people at risk for Alzheimer’s disease so they can better understand how to potentially anticipate and prevent the disease. They are also conducting experimental drug trials, and learning about the disease through brain imaging, neurocognitive testing and basic research on the pathological hallmarks of Alzheimer’s disease.
Principal investigators for Alzheimer’s disease research include Yousef Al-Abed; Peter Davies; Concepcion Goldberg; Terry E. Goldberg; Marc L. Gordon; Patricio T. Huerta; Jeremy Koppel; Jian Yi Li; Philippe Marambaud; Thomas L. Rothstein and Chris C. Tang.